Skip to main content

Day: June 21, 2021

StoneMor Inc. Announces Record Date for Annual Meeting of Stockholders

BENSALEM, Pa., June 21, 2021 (GLOBE NEWSWIRE) — StoneMor Inc. (NYSE: STON) (“StoneMor”) today announced that the record date for stockholders entitled to notice of and to vote at the 2021 Annual Meeting of Stockholders (the “Annual Meeting”) has been changed from the close of business on Friday, June 4, 2021 to the close of business on Monday, June 21, 2021.   The Annual Meeting will be held on Tuesday, July 27, 2021 at 4:00 p.m. EDT and will be held by remote communication. Information regarding the manner in which stockholders will be able to access, participate in and vote at the Annual Meeting will be set forth in the Company’s proxy statement. About StoneMor Inc. StoneMor, headquartered in Bensalem, Pennsylvania, is an owner and operator of cemeteries and funeral homes in the United States, with 318 cemeteries and 88 funeral...

Continue reading

Ayr Wellness Opens Third Pennsylvania Dispensary in Gibsonia

TORONTO, June 21, 2021 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTC: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated cannabis multi-state operator, announced today the opening of the third Ayr medical dispensary in the Commonwealth of Pennsylvania, located in Gibsonia, a suburb of Pittsburgh. The Ayr Wellness dispensary is the third in the state opened by CannTech PA, LLC, a wholly-owned Ayr subsidiary. The strategic location, just off Route 8 at 112 Northtowne Square, Gibsonia, PA 15044, will see over 33,000 cars drive by per day. The 8,000 sq. ft. facility has 45 parking spaces and is designed to fit up to 30 point-of-sale stations. The dispensary will employ ~20 people from the local community and is located in the building that once housed King’s Restaurant, an iconic family staple that has been closed...

Continue reading

ThreeD Capital Inc. Commences Trading on the OTCQX Market

TORONTO, June 21, 2021 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce that its common shares are now trading on the OTCQX® Best Market (“OTCQX”) under the ticker symbol “IDKFF”. ThreeD has been upgraded to OTCQX from the OTCQB® Venture Market. The OTCQX is the highest market tier of OTC Markets. The Company believes that trading on OTCQX will enhance the visibility and accessibility of the Company to U.S. investors, which will allow more investors to participate in the growth of the Company. ThreeD’s common shares will continue to trade on the Canadian Stock Exchange (“CSE”) under the symbol “IDK”. Sheldon Inwentash,...

Continue reading

Hill International Awarded Contract by Leading UAE Real Estate Developer Aldar Properties to Oversee Infrastructure Upgrades in Abu Dhabi

PHILADELPHIA and ABU DHABI, United Arab Emirates, June 21, 2021 (GLOBE NEWSWIRE) — Hill International (NYSE:HIL), delivering the infrastructure of change, announced today it has been awarded a contract by Aldar Projects LLC, the project delivery arm of UAE real estate developer Aldar Properties, to provide project management services for infrastructure upgrades in Abu Dhabi. The project consists of two distinct elements: The Zayed Link Road and Tal Moreeb Road. The Zayed Link Road project will refurbish and double the capacity of the existing link road between the E11 highway and the Madinat Zayed military airfield near the city of Madinat Zayed in the Al Dhafra Region. In total approximately 50 km (32 miles) of road will be converted from existing single carriageway (one lane in each direction) to dual carriageway (two lanes in...

Continue reading

Portfolio and NAV Update

THIS ANNOUNCEMENT HAS BEEN DETERMINED TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF MARKET ABUSE REGULATION (EU) NO. 596/2014, WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. Crown Place VCT PLCLEI Code 213800SYIQPA3L3T1Q68Portfolio and NAV Update Crown Place VCT PLC (the “Company”) is pleased to report that two companies within its portfolio are undergoing external fundraising processes. The Manager’s current view of the effect of these events on the valuations, as at today’s date, is an uplift of 1.81 pence per share (5.73%) to the most recently announced net asset value (“NAV”) of 31.59 pence per share (being the 31 March 2021 NAV). A further update will be made...

Continue reading

Portfolio and NAV Update

THIS ANNOUNCEMENT HAS BEEN DETERMINED TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF MARKET ABUSE REGULATION (EU) NO. 596/2014, WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. Albion Enterprise VCT PLCLEI Code 213800OVSRDHRJBMO720Portfolio and NAV Update Albion Enterprise VCT PLC (the “Company”) is pleased to report that two companies within its portfolio are undergoing external fundraising processes. The Manager’s current view of the effect of these events on the valuations, as at today’s date, is an uplift of 7.79 pence per share (6.94%) to the most recently announced net asset value (“NAV”) of 112.23 pence per share (being the 31 December 2020 NAV adjusted for the...

Continue reading

Portfolio and NAV Update

THIS ANNOUNCEMENT HAS BEEN DETERMINED TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF MARKET ABUSE REGULATION (EU) NO. 596/2014, WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. Kings Arms Yard VCT PLCLEI Code 213800DK8H27QY3J5R45Portfolio and NAV Update Kings Arms Yard VCT PLC (the “Company”) is pleased to report that two companies within its portfolio are undergoing external fundraising processes and an additional portfolio company is in the process of an exit. The Manager’s current view of the effect of these events on the valuations, as at today’s date, is an uplift of 1.23 pence per share (5.67%) to the most recently announced net asset value (“NAV”) of 21.70 pence...

Continue reading

Portfolio and NAV Update

THIS ANNOUNCEMENT HAS BEEN DETERMINED TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF MARKET ABUSE REGULATION (EU) NO. 596/2014, WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. Albion Development VCT PLCLEI Code 213800FDDMBD9QLHLB38Portfolio and NAV Update Albion Development VCT PLC (the “Company”) is pleased to report that two companies within its portfolio are undergoing external fundraising processes. The Manager’s current view of the effect of these events on the valuations, as at today’s date, is an uplift of 5.77 pence per share (7.04%) to the most recently announced net asset value (“NAV”) of 82.01 pence per share (being the 31 March 2021 NAV adjusted for the...

Continue reading

Syneos Health Accelerates Decentralized Clinical Trial Delivery, Unveils New Collaboration with Site Sponsors

Newly Established Site Advocacy Group will Deliver Deeper, More Meaningful Site-Based Insights to Drive Adoption of Decentralized Clinical Trials Methodologies & Technologies MORRISVILLE, N.C., June 21, 2021 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today expanded its Decentralized Clinical Trial capabilities to include a dedicated Decentralized Clinical Trials Site Advocacy Group, continuing the momentum for Decentralized Solutions demonstrated by the recent acquisition of Illingworth Research Group to move clinical trials closer to the patient. Decentralized Solutions from Syneos Health combines deep insights, agile technologies, innovative trial design experience and operational excellence – transforming product development. This novel, industry-leading...

Continue reading

OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics

MIAMI, June 21, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that its subsidiary EirGen Pharma has entered into an agreement with Nicoya Macau Limited, an affiliate of Nicoya Therapeutics (Nicoya), for the development and commercialization in Greater China (mainland China, Hong Kong, Macau and Taiwan) of RAYALDEE® for the treatment of secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD). Nicoya is a leading biotechnology company incubated by 6 Dimensions Capital and its successor fund 120 Capital and other co-investors, and is focusing on the Greater China nephrology market. Nicoya will make an upfront payment to OPKO of $5 million and an additional $5 million payment will be made during the first 12 months of the agreement or upon Nicoya achieving a certain...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.